Sequoia Vaccines
Chemicals & Related Products · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1912 Innerbelt Business Center Dr, Saint...Phone Number
(314) 373-5181Website
www.sequoiavaccines.comRevenue
<$5 MillionIndustry
About Sequoia Vaccines
Sequoia Vaccines, Inc. is a clinical-stage pharmaceutical company dedicated to the discovery and development of innovative vaccines aimed at preventing bacterial infections, particularly recurrent urinary tract infections (UTIs), and treating specific cancers and lung infections associated with cystic fibrosis. Their product pipeline includes SEQ-400, a FimH vaccine for recurrent UTIs, and drug candidates targeting ovarian/uterine cancer and lung infections in cystic fibrosis patients. The company is committed to combating antimicrobial resistance and cancer through its advanced research programs. With a leadership team boasting over 100 years of combined experience in pharmaceutical R&D and clinical development, Sequoia Vaccines prioritizes patient outcomes in its mission.Explore more
SIC Code 28,283NAICS Code 32,325Show moreSequoia Vaccines Org Chart
Compare Similar Companies to Sequoia Vaccines
Compare insights from companies similar to Sequoia Vaccines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sequoia Vaccines Tech Stack
A closer look at the technologies used by Sequoia Vaccines
See more technologies
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sequoia Vaccines
Sign Up For FreeTo access detailed company insights
Sequoia Vaccines, Inc. is a clinical-stage pharmaceutical company dedicated to the discovery and development of innovative vaccines aimed at preventing bacterial infections, particularly recurrent urinary tract infections (UTIs), and treating specific cancers and lung infections associated with cystic fibrosis. Their product pipeline includes SEQ-4... Read More